Literature DB >> 12772293

The structure of the sugar residue in glycated human serum albumin and its molecular recognition by phenylboronate.

Jan Rohovec1, Thomas Maschmeyer, Silvio Aime, Joop A Peters.   

Abstract

Quantification of the extent of glycation of human serum albumin (HSA) and of haemoglobin provides a record of average mid- and long-term blood-sugar concentrations, respectively; this is very useful for the management of diabetes. The reaction of D-glucose with propylamine affords the corresponding Schiff base, N-propylamino-D-glucoside, in the cyclic form. This compound is not stable: upon standing or treatment with acid it is converted, by an Amadori rearrangement, into N-propylfructosamine. Both amino sugars occur predominantly in the beta-pyranose form. Phenylboronate forms highly stable boronate esters through binding of the cis 1,2-diol moiety in the furanose form of N-propylfructosamine. Between pH 5 and 10, an electrostatic interaction between the protonated amino group and the negatively charged boronate moiety affords an additional stabilisation of the ester. The Schiff base, however, has no observable interaction with phenylboronate. In aqueous solution the Schiff base is in equilibrium with propylamine and glucose. Upon addition of phenylboronate, this equilibrium shifts to the side of glucose due to the formation of highly stable phenylboronate esters of the beta-furanose form of this compound. After Amadori rearrangement, the sugar moieties in glycated human serum albumin have a similar structure, they occur as an equilibrium of the beta-pyranose (59%), alpha-furanose (19%) and beta-furanose (24%) anomers. The open form was not observed. The beta-furanose anomer is selectively recognised by phenylboronate.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12772293     DOI: 10.1002/chem.200204632

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  6 in total

1.  Toward the Design of MR Agents for Imaging β-Cell Function.

Authors:  Mark Woods; Shanrong Zhang; A Dean Sherry
Journal:  Curr Med Chem Immunol Endocr Metab Agents       Date:  2004-12

2.  Papaverine increases human serum albumin glycation.

Authors:  Alireza Ahmadzadeh
Journal:  J Biol Phys       Date:  2014-01-12       Impact factor: 1.365

3.  Development of affinity microcolumns for drug-protein binding studies in personalized medicine: interactions of sulfonylurea drugs with in vivo glycated human serum albumin.

Authors:  Jeanethe Anguizola; K S Joseph; Omar S Barnaby; Ryan Matsuda; Guadalupe Alvarado; William Clarke; Ronald L Cerny; David S Hage
Journal:  Anal Chem       Date:  2013-04-17       Impact factor: 6.986

4.  Impact of glycation on antibody clearance.

Authors:  Jane Yang; Ronya Primack; Mike Frohn; Wei Wang; Peng Luan; Marc W Retter; Gregory C Flynn
Journal:  AAPS J       Date:  2014-11-21       Impact factor: 4.009

5.  Effects of Fatty Acids and Glycation on Drug Interactions with Human Serum Albumin.

Authors:  Jeanethe A Anguizola; Sara B G Basiaga; David S Hage
Journal:  Curr Metabolomics       Date:  2013-09-01

Review 6.  Boronic Acid-based approach for separation and immobilization of glycoproteins and its application in sensing.

Authors:  Xiaojin Wang; Ning Xia; Lin Liu
Journal:  Int J Mol Sci       Date:  2013-10-17       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.